Previous Article | Next Article 
Infection and Immunity, September 2000, p. 5210-5217, Vol. 68, No. 9
Division of Infectious Diseases, Department
of Internal Medicine,1 Center for the
Study of Emerging and Re-emerging
Pathogens,2 and Department of
Microbiology and Molecular Genetics,3
University of Texas Medical School, Houston, Texas 77030
Received 10 April 2000/Returned for modification 12 May
2000/Accepted 16 June 2000
Our previous work reported that most Enterococcus
faecalis strains adhered to the extracellular matrix proteins
collagen types I and IV and laminin after growth at 46°C, but not
37°C, and we subsequently identified an E. faecalis
sequence, ace, that encodes a bacterial adhesin similar to
the collagen binding protein Cna of Staphylococcus aureus.
In this study, we examined the diversity of E. faecalis-specific ace gene sequences among different
isolates obtained from various geographic regions as well as from
various clinical sources. A comparison of nucleotide and deduced amino acid sequences of Ace from nine E. faecalis strains
identified a highly conserved N-terminal A domain, followed by a
variable B domain which contains two to five repeats of 47 amino acids in tandem array, preceded by a 20-amino-acid partial repeat. Using 17 other strains collected worldwide, the 5' region of ace
that encodes the A domain was sequenced, and these sequences showed Enterococci normally colonize the
intestinal tract, but these organisms, particularly Enterococcus
faecalis, are also known to cause many clinical infections in
humans, including septicemia, bacteremia, urinary tract infections, and
5 to 15% of cases of bacterial endocarditis (15). The
existing knowledge of the factors that may influence the ability of
enterococci to colonize host tissues, translocate across epithelial
barriers, and survive in different host environments is rudimentary,
but their increasing resistance to multiple antimicrobial drugs makes
the study of pathogenesis of these organisms all the more important
(18).
Interactions with host cells and colonization of mucosal surfaces are
considered to be primary events in the pathogenesis of many infections
(2). The pathogenesis of bacterial endocarditis is believed
to begin with bacterial adhesion to the extracellular matrix (ECM) of
damaged heart tissue. Bacterial surface adhesins have been suggested to
play a major role in adherence and colonization. Staphylococci are
known to bind to a large number of proteins present in the host ECM.
Molecular characterization and functional characterization have
identified a number of proteins, such as a collagen binding protein,
Cna (22), fibronectin binding proteins (12, 29),
and fibrinogen binding proteins (3, 5), collectively named
microbial surface components recognizing adhesive matrix molecules
(MSCRAMMs) (21), that mediate binding to ECM proteins. MSCRAMMs typically share some common structural features: (i) a short
signal sequence followed by a nonrepetitive region, which in most cases
is responsible for binding to ECM proteins; (ii) a repetitive region
that exhibits variation among strains; and (iii) a C-terminal domain
that includes an LPXTG anchoring motif and a hydrophobic
membrane-spanning domain followed by a short tail rich in positively
charged amino acids (8, 21).
Our recent work identified a gene in E. faecalis coding for
a putative protein designated as Ace that has characteristics similar
to those of the collagen binding protein Cna of Staphylococcus aureus (25). The Ace sequence from E. faecalis strain V583 shows a putative N-terminal signal sequence
followed by a 335-amino-acid-long A domain. The B domain is composed of
4.4 tandemly repeated 47-residue units of >90% identity. A cell
wall-associated domain rich in proline residues that contains the cell
wall-anchoring LPXTG consensus sequence and a hydrophobic transmembrane
region of 18 amino acids followed by a short cytoplasmic tail
represents the carboxy-terminal end of the protein
(25). This work also localized the collagen type I (CI)
binding property of Ace produced by E. faecalis
strain EF1 to the A domain based on biochemical evidence. More recent results, submitted as a companion paper, demonstrate that Ace mediates
the 46°C-evoked adherence of strain OG1RF to collagen type IV (CIV)
and mouse laminin (LN) (19) in addition to CI (25).
In the current study, we have studied sequence variation in the
E. faecalis ace genes. Since most strains of E. faecalis exhibit conditional binding (i.e., after growth at
46°C), we also attempted to detect Ace proteins from bacterial
protein preparations made from cultures grown at both 37 and 46°C.
Finally, in an effort to find evidence of expression of ace
under more physiological conditions than 46°C, we have examined sera
from patients with enterococcal infections for the presence of
antibodies to Ace.
Bacterial strains.
The E. faecalis and
Enterococcus faecium isolates used in this study were
selected, in most cases, arbitrarily from our laboratory collection
(obtained over a 20-year period from various locations in the United
States, Argentina, Thailand, Lebanon, and Spain); many of them have
been well characterized and are known not to be clonally derived
(6, 10, 14, 16, 36). These isolates were obtained from
wounds, urine, feces, and blood, including endocarditis. E. faecalis strains OG1RF, JH2-2, and V583 have been described
previously (11, 17, 27).
Culture conditions.
Enterococci were grown in brain heart
infusion broth or agar (Difco Laboratories, Detroit, Mich.) at
37°C for routine purposes or at 46°C. Escherichia
coli cells were grown in Luria-Bertani (LB) broth or on LB agar
with appropriate antibiotics overnight at 37°C. The concentrations of
antibiotics used for E. coli were kanamycin at 50 µg/ml
and ampicillin at 50 to 100 µg/ml.
General DNA techniques.
Routine DNA techniques were
performed by standard methods (28). Chromosomal DNA from
E. faecalis was isolated according to the previously
described method (17). PCR amplifications were performed
with a DNA thermal cycler (Perkin-Elmer Corp., Norwalk, Conn.) and
synthetic oligonucleotide primers purchased either from Life
Technologies (Grand Island, N.Y.) or from Genosys Biotechnologies, Inc.
(Woodlands, Tex.).
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Diversity of ace, a Gene Encoding a Microbial Surface
Component Recognizing Adhesive Matrix Molecules, from Different Strains
of Enterococcus faecalis and Evidence for Production
of Ace during Human Infections
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
97.5% identity. Among the previously reported five amino acids critical for collagen binding by Cna of S. aureus, four
were found to be identical in Ace from all strains tested. Polyclonal
immune rabbit serum prepared against recombinant Ace A derived from
E. faecalis strain OG1RF detected Ace in mutanolysin
extracts of seven of nine E. faecalis strains after growth
at 46°C; Ace was detected in four different molecular sizes that
correspond to the variation in the B repeat region. To determine if
there was any evidence to indicate that Ace might be produced under
physiological conditions, we quantitatively assayed sera collected from
patients with enterococcal infections for the presence of anti-Ace A
antibodies. Ninety percent of sera (19 of 21) from patients with
E. faecalis endocarditis showed reactivity with titers from
1:32 to >1:1,024; the only 2 sera which lacked antibodies to Ace A had
considerably lower titers of antibodies to other E. faecalis antigens as well. Human-derived, anti-Ace A
immunoglobulins G purified from an E. faecalis endocarditis
patient serum inhibited adherence of 46°C-grown E. faecalis OG1RF to collagen types I and IV and laminin. In
conclusion, these results show that ace is highly conserved
among isolates of E. faecalis, with at least four variants
related to the differences in the B domain, is expressed by different
strains during infection in humans, and human-derived antibodies can
block adherence to these extracellular matrix proteins.
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
Antiserum to the Ace A domain of OG1RF.
The cloning and
expression of the E. faecalis OG1RF ace gene,
coding for all 335 amino acids of the Ace A domain, generation of
polyclonal serum against this purified recombinant Ace A, and reactions of this serum with OG1RF have been described elsewhere (19) (Table 2).
|
Western blotting. Protein extracts from E. faecalis cultures grown at 37 and 46°C were prepared by the mutanolysin extraction method as described in the companion paper (19). Mutanolysin extracts from E. faecalis strains were electrophoresed on 4 to 12% NuPAGE Bis-Tris gels (NOVEX, San Diego, Calif.) under reducing conditions in MOPS (3-[N-morpholino]propanesulfonic acid) buffer and transferred to a polyvinylidene difluoride (PVDF) membrane. The presence of Ace protein was detected by incubation with either the anti-Ace A polyclonal antiserum described above or eluted antibodies from human endocarditis serum (antibody I) followed by protein A-horseradish peroxidase conjugate (antibody II) and development with 4-chloronaphthol in the presence of H2O2.
Human sera. From our laboratory collection of sera (collected from different medical centers in the United States), four study groups that were grouped based on the diagnosis of infection were selected for analysis. Serum samples known to have antibodies against enterococcal total proteins from previous studies (1, 33, 39, 40) were included. Strains isolated from patients who had donated serum but which were not available to us, and hence could not be identified to the species level in our laboratory, were classified as enterococcal species unknown (ESU). Sera from 21 patients with E. faecalis endocarditis (including some corresponding to strains studied here) and four patients with ESU endocarditis constituted one group. A second group consisted of nine serum samples collected from patients with E. faecalis nonendocarditis infections, such as bacteremia, urosepsis, and osteomyelitis, and three sera obtained from ESU nonendocarditis infections. The third study group consisted of serum samples from six patients with E. faecium endocarditis, one patient with E. faecium urosepsis, and two patients with streptococcal infections. The final group, consisting of 12 sera obtained from hospitalized patients (HPS) with no knowledge of their diagnosis or of any infection, was included as a nonhealthy control group. Available normal human sera (NHS) from our laboratory collection, previously pooled in groups of two to three from a total of 20 healthy volunteers, were used as a healthy control group.
ELISA. An enzyme-linked immunosorbent assay (ELISA) using human sera was performed by a previously described method with some modifications (1). Polystyrene microtiter plates (Dynatech Laboratories, Inc., Alexandria, Va.) were coated with 50 ng of recombinant Ace A protein from OG1RF in 100 µl of phosphate-buffered saline (PBS) and allowed to incubate overnight at 4°C. Wells were washed five times with PBST (PBS with 0.01% Tween 20). After blocking wells with 3% bovine serum albumin (BSA) at 37°C in PBST, wells were washed three times with PBST. Each serum was assayed in duplicate in serial dilutions of 1:16 to 1:2,048 in 1% BSA. Goat anti-human immunoglobulin G (IgG)-peroxidase conjugate was used for detection of human antibodies to Ace. A450 was measured following the addition of 3,3',5,5'-tetramethylbenzidine and H2O2. Titers were determined after subtracting values from appropriate negative controls. For control sera, the optical density at 450 nm (OD450) was measured at each dilution. The sum of the average OD450 value and two times the standard deviation was calculated for each dilution and used as the cutoff value for determining serum titers. A one-tailed Student's t test was used to compare Ace A antibody levels among the four groups of subjects.
Enrichment of Ace-specific antibodies by elution and their effect on adherence. Recombinant Ace protein was electrophoresed in 10% NuPAGE Bis-Tris gels (NOVEX), transferred to a PVDF membrane, and incubated with E. faecalis endocarditis serum S0032. Ace A-specific antibody elution was performed by the procedure described elsewhere (40). Inhibition of enterococcal adherence to CI, CIV, and LN with IgGs affinity purified from normal human sera or from an E. faecalis endocarditis patient serum, S0032, was carried out as described elsewhere for rabbit sera (19). Results are presented as percentage of cells bound, based on the formula (radioactivity of bound cells/radioactivity of total cells added) × 100.
Nucleotide sequence accession numbers. The Ace nucleotide sequences reported here were submitted to GenBank under accession numbers AF260872 to AF260896.
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
E. faecalis ace sequences.
DNA sequencing and
analysis revealed that the ace gene of E. faecalis OG1RF is 2,166 bp in length, encoding a putative
polypeptide of 721 amino acids (Fig. 1A).
As was previously reported for Ace of E. faecalis strain
EF1, the first 31 residues have the properties of a signal peptide,
with a charged region followed by hydrophobic residues (25).
The N-terminal region is composed of a 335-amino-acid A domain,
followed by a tandemly repeated B domain (Fig. 1A). In the B domain, 47 amino acids are repeated five times preceded by a short 20-amino-acid
partial repeat (Fig. 1D). Recer (recombinant sites in genes that also
serve as flexible spacers in the protein) sequences previously
described by de Chateau and Bjork (7), GAA AAT CcA GAT GAA
coding for presumably unstructured ENPDE, were identified in the
nucleotide sequence at the boundary between each B repeat. The
C-terminal region is composed of a cell wall domain with conserved
LPKTG anchorage residues, followed by an 18-amino-acid hydrophobic
membrane-spanning domain and a short cytoplasmic tail as previously
found for EF1 (25). The predicted molecular mass of the Ace
protein of OG1RF after signal peptide processing is 75.6 kDa.
|
Y
denotes the respective amino acid change. The number in parentheses
denotes the number of strains in which the amino acid change was
observed in the 26 sequenced strains. (D) Amino acid sequence of B
repeats of OG1RF. Nonidentical amino acids are shaded.
Correlation of in vitro expression of Ace and of adherence.
Table 2 summarizes the adherence characteristics and results of probing
mutanolysin-phenylmethylsulfonyl fluoride (PMSF) extract concentrates
of eight different strains of E. faecalis (as well as
results with OG1RF described in the companion paper [19]) with polyclonal immune serum raised against
recombinant OG1RF Ace A. After growth at 37°C, a single ~105-kDa
protein band was seen in extracts of the E. faecalis END6
strain, and there was a single ~86-kDa weakly positive band for the
E. faecalis MC02152 strain (Fig.
2), whereas no band was detected in
extracts of the remaining six strains tested. Probing of
mutanolysin extracts prepared from these eight E. faecalis strains grown at 46°C with anti-Ace A antibodies
showed a single reactive protein band in six E. faecalis
strains (Table 2 and Fig. 2). The four observed sizes of protein bands
are in concordance with the different numbers of B repeats (Table 2).
No band was detected in extracts prepared from LBJ-1 grown at 37 or
46°C, and, as anticipated from sequencing data, no protein band was
detected in E. faecalis SE47b. The adherence phenotype of
these E. faecalis strains to CI, CIV, and LN was retested,
and the results are presented in Table 2. In addition to two previously
reported E. faecalis strains, END6 and SE47b, which
showed adherence to collagens and/or LN even after growth at 37°C
(38), E. faecalis MC02152 grown at 37°C
showed low-level binding to ECM proteins (6% to CI, 8.9% to CIV, and
7.1% to LN), while the remaining E. faecalis strains showed
<5% binding after growth at 37°C; the latter strains were
considered as adherence negative, since we use 5% of cells bound as a
cutoff to define adherence. Seven of these strains, excluding LBJ-1,
showed a marked increase (to 20%) in adherence to CI, CIV, and LN
after growth at 46°C. Of note, strain SE47b, which showed significant
binding to CI, CIV, and LN after growth at both 37 and 46°C
(38; this study) also showed a high degree of
clumping under in vitro culture conditions, which may have resulted in
high counts of clumped cells, leading to a high percent of binding by a
non-Ace-mediated mechanism at both 37 and 46°C. IgGs purified from
anti-Ace A rabbit immune serum were unable to inhibit adherence of
SE47b (data not shown).
|
Reactivity of serum from humans with enterococcal infections with
Ace A recombinant protein.
We initially screened several
E. faecalis endocarditis sera by Western blotting. Among
five sera, one (S0032) showed strong reactivity, and three
reacted moderately to recombinant Ace A protein, suggesting that in
vivo expression of ace by different strains had occurred in
these patients (Fig. 3). Serum from a patient with E. faecium endocarditis did not react with
recombinant Ace A.
|
|
Ability of IgGs from endocarditis serum to inhibit adherence of
E. faecalis OG1RF to ECM proteins.
We examined the
ability of IgGs purified from a high-Ace A-titer E. faecalis
endocarditis patient serum, S0032 (HTS), to inhibit adherence of
46°C-grown E. faecalis OG1RF to CI, CIV, and LN. Preincubation of OG1RF with IgGs from this serum at concentrations greater than 2 mg/ml inhibited adherence to CI, CIV, and LN by about
16- to 24-fold relative to NHS, as shown in Table
3. Purified IgGs from NHS had a
negligible effect on adherence at these concentrations.
|
|
Lack of evidence of an ace homolog in non-E. faecalis species. Our recent hybridization results with several enterococcal strains with the 1,090-bp ace probe (amplified with AceF2a and AceR3a) indicated that ace is specific to E. faecalis strains (R. W. Duh, K. V. Singh, K. Malathum, and B. E. Murray, submitted for publication). Southern hybridization of DNA preparations from nine E. faecium strains with the 419-bp conserved ace DNA probe under low-stringency conditions showed no bands, further implying the absence of a close ace homolog in E. faecium.
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
Our earlier investigation has reported a conditional adherence phenotype among most E. faecalis isolates (38). Following this, we identified an E. faecalis gene, ace, that encodes a putative adhesin (Ace) and presented evidence for its role in binding to CI (25). In our companion paper, we disrupted the ace gene in the laboratory strain OG1RF and reported that Ace mediates adherence to CIV and LN in addition to CI (19).
In the current study, we examined the diversity of the ace
gene in different E. faecalis strains. Our initial
amplification of ace sequences from 15 E. faecalis isolates by PCR showed DNA fragments of four different
sizes. To explain this observed size difference and to investigate the
extent of differences in ace sequences among E. faecalis isolates obtained from different sources, we sequenced
the complete ace gene from eight selected E. faecalis strains. Comparison of the nucleotide and deduced amino
acid sequences of Ace from these strains with that available for
the V583 strain from The Institute of Genomic Research database showed
the highly conserved N-terminal regions representing the A domain,
followed by the variable B repeat region. Analysis of these sequences
revealed that ace occurred in four different forms relating
to variation in the B repeat numbers. Similarly, four molecular sizes
of Ace proteins were observed on Western blots probed with
anti-Ace A immune rabbit serum. As reported earlier for Ace proteins
from E. faecalis strains OG1RF (19), EF1, and EF2
(25), the observed molecular sizes of Ace detected on
Western blots of extracts from different E. faecalis strains
were found to be larger than the predicted sizes based on deduced amino
acid sequences, perhaps due to their highly acidic nature, as shown in
Table 2. Consensus 15-nucleotide recer sequences were identified
between each B repeat. Earlier analysis of recer sequences in
Peptostreptococcus magnus suggested their possible role in
recombination of new incoming modules at the DNA level (7).
Similarly, at the protein level, the proline residues in ENPDE recer
sequences have been proposed to promote lack of structure, thus
allowing interdomain flexibility. No recer sequences were reported in
staphylococcal collagen binding gene cna. Although we do not
have any direct evidence of recombination occurring at recer sequences,
this may possibly explain the variation in B repeats. We have yet to
characterize the function of the B domain. Although several functions
were predicted for the B domains of Cna of S. aureus, recent
detailed studies were unable to prove any such functions (9, 24,
32). Further sequencing of the N-terminal ace region
that codes for the A domain, the region we previously showed is
involved in binding to CI (25), from 17 additional strains
collected worldwide showed 97.5% identity, indicating the highly
conserved nature of this functional domain. In one of these strains,
E. faecalis SE47b, the ace gene was interrupted by a stop codon, as will be discussed further below.
We also attempted to correlate the in vitro production of Ace with the observed phenotype (i.e., binding to ECM proteins CI, CIV, and LN after growth at 37 or 46°C). In Western blots, Ace was detected in extracts of only two E. faecalis strains after growth at 37°C, of which one strain, END6, had been previously noted to bind to CI and CIV after growth at 37°C (38). The other strain, MC02152, which showed a faintly positive band after growth at 37°C, exhibited low-level binding to CI, CIV, and LN. This is in contrast to the majority of E. faecalis strains (for which no band was detected after growth at 37°C) which showed <5% binding after growth at 37°C; since we use 5% of cells bound as a cutoff to define adherence, these isolates were considered as adherence negative. Consistent with the observed binding of 46°C-grown E. faecalis strains to CI, CIV, and LN, the Ace protein was detected in most 46°C-grown E. faecalis strains. With MC02152, a much more strongly positive band was observed on the Western blot after growth at 46°C, and its binding increased to 29% to CI, 38% to CIV, and 41% to LN. Our companion paper also reports identification of a single ~105-kDa Ace protein band from 46°C-grown E. faecalis OG1RF extracts, but not from 37°C-grown extracts (19). With E. faecalis LBJ-1, we were unable to detect an Ace protein band on the Western blot with extracts prepared from 37- or 46°C-grown cells, and it is the only strain that showed no adherence to CI, CIV, and LN after growth at either temperature. Similarly, as anticipated from sequencing data, no Ace protein band was found in extracts of SE47b, the strain whose binding was not reduced by anti-Ace A IgGs, indicating a non-Ace-mediated adherence; this strain shows a high degree of clumping in broth which may explain its apparent binding to ECMs. Thus, the observed conditional expression of Ace protein correlates with conditional adherence (i.e., after growth at 46°C) of E. faecalis strains (38). Since adhesin genes of other pathogenic bacteria have been shown to be environmentally regulated (13, 20, 37), the absence of in vitro production of Ace at 37°C is not unprecedented.
In an effort to determine if there was evidence of Ace expression under physiological conditions, we analyzed the antibody levels to recombinant Ace A by using a diversified serum collection from patients from different medical centers with various types of infections caused by different strains. Our results showed significantly higher anti-Ace A IgG levels among most sera obtained from E. faecalis endocarditis patients as well as in some sera from other E. faecalis infections. The two E. faecalis endocarditis sera that were nonreactive with Ace had much lower total enterococcal antibody levels. Since we lack information about the time of serum collection relative to the onset of illness, it is possible that these negative sera were drawn early in infection. One of six sera from E. faecium endocarditis patients also showed reactivity to Ace A protein. Since Southern hybridization of genomic DNA isolated from this strain with the ace probes, even under low-stringency conditions, showed an absence of hybridization, these antibodies may be the result of a prior infection with E. faecalis. It is of interest that the endocarditis serum from the patient infected with LBJ-1 had Ace A antibodies (titer, 1:256). As described earlier, this strain showed neither conditional adherence nor in vitro Ace expression by Western blots, but the presence of antibodies suggests that Ace was expressed at the time of infection or, possibly, during some prior infection. These results indicate that Ace is commonly expressed in vivo during infection by different strains. Similar to our findings that suggest Ace is produced in vivo, although usually not at levels detectable by our assays when grown at 37°C in vitro, we have observed other antigens that reacted with sera from patients with enterococcal infections, but not with rabbit polyclonal serum raised against protein extracts from a 37°C-grown E. faecalis endocarditis isolate (39). We have also observed this with the polysaccharide gene cluster of E. faecalis, for which we have evidence of in vivo, but not in vitro, production, except for an unusual mucoid strain, which expresses a polysaccharide antigen at a lower temperature (41).
In the bacterial ECM adherence assay, inhibition was obtained with IgGs from a high-Ace A-titer E. faecalis endocarditis patient serum, S0032, and with Ace A-specific eluted antibodies derived from this serum. The eluted Ace-specific antibodies reacted only with an ~105-kDa band from extracts of OG1RF grown at 46°C (but not 37°C), indicating the specificity of the eluted antibodies. A recent study of the antibody response to fibronectin binding protein A in patients with S. aureus infections detected considerable variation in IgG levels that reacted with the ligand binding repeat domain of FnBpA. However, these antibodies were unable to block fibronectin binding (4).
Our recent study showed that ace is specific to E. faecalis, because none of the non-E. faecalis enterococcal isolates hybridized to an ace probe, and ace is present in all E. faecalis isolates regardless of their clinical source (Duh et al., submitted); this is different from what is seen with the staphylococcal ace homolog, cna (encoding a collagen binding adhesin of S. aureus), which is present in only 38 to 56% of S. aureus strains (26, 31, 34). In an effort to identify homologs of ace in E. faecium, we have carried out Southern hybridizations under low-stringency conditions. The absence of a close ace homolog in E. faecium is in contrast to our identification of homologs in E. faecium of other E. faecalis genes (e.g., efaA) (30) and a polysaccharide gene cluster (unpublished observation) under low-stringency hybridization conditions.
In conclusion, analysis of ace sequences from E. faecalis strains collected from patients worldwide showed
that the E. faecalis-specific gene ace
occurs in at least four different forms, with 97.5% identity in the
region encoding the A domain and more apparent variation in the
region coding for the B domain, due to variation in the number of
repeats. Conditional (after growth at 46°C) in vitro expression
of Ace, detected with polyclonal antibodies to OG1RF-derived
recombinant Ace A, correlated with our previously described conditional
adherence of these E. faecalis strains to ECM proteins.
Identification of Ace-specific antibodies in sera obtained from
patients with enterococcal infections, especially patients with
E. faecalis endocarditis, indicates that Ace is commonly
expressed in vivo during infection in humans, not just at 46°C in
vitro. Investigation of a possible role for Ace in pathogenesis and
elucidation of whether the ability of these antibodies to block
adherence of E. faecalis to ECM proteins has any potential protective effects in vivo will be the subject of our future studies.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by NIH grant AI33516 from NIAID, the Division of Microbiology and Infectious Diseases, to B. E. Murray.
We are grateful to J. E. Patterson, University of Texas Health Science Center at San Antonio, San Antonio, Tex., and J. M. Steckelberg, Mayo Clinic, Rochester, Minn., for providing some of the sera and strains used in this study.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Center for the Study of Emerging and Re-emerging Pathogens, Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical School at Houston, 6431 Fannin St., Houston, TX 77030. Phone: (713) 500-6767. Fax: (713) 500-5495. E-mail: infdis{at}heart.med.uth.tmc.edu.
Present address: Section of Infectious Diseases, Department of
Medicine, Veterans General Hospital
Taipei, Taipei, Taiwan, Republic
of China.
Editor: E. I. Tuomanen
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. |
Arduino, R. C.,
B. E. Murray, and R. M. Rakita.
1994.
Roles of antibodies and complement in phagocytic killing of enterococci.
Infect. Immun.
62:987-993 |
| 2. | Beachey, E. H. 1981. Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J. Infect. Dis. 143:325-345[Medline]. |
| 3. | Bodén, M. K., and J. I. Flock. 1994. Cloning and characterization of a gene for a 19 kDa fibrinogen-binding protein from Staphylococcus aureus. Mol. Microbiol. 12:599-606[CrossRef][Medline]. |
| 4. |
Casolini, F.,
L. Visai,
D. Joh,
P. G. Conaldi,
A. Toniolo,
M. Höök, and P. Speziale.
1998.
Antibody response to fibronectin-binding adhesin FnbpA in patients with Staphylococcus aureus infections.
Infect. Immun.
66:5433-5442 |
| 5. | Cheung, A. I., S. J. Projan, R. E. Edelstein, and V. A. Fischetti. 1995. Cloning, expression, and nucleotide sequence of a Staphylococcus aureus gene (fbpA) encoding a fibrinogen-binding protein. Infect. Immun. 63:1914-1920[Abstract]. |
| 6. | Coque, T. M., J. E. Patterson, J. M. Steckelberg, and B. E. Murray. 1995. Incidence of hemolysin, gelatinase, and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. J. Infect. Dis. 171:1223-1229[Medline]. |
| 7. |
de Château, M., and L. Björck.
1996.
Identification of interdomain sequences promoting the intronless evolution of a bacterial protein family.
Proc. Natl. Acad. Sci. USA
93:8490-8495 |
| 8. | Foster, T. J., and M. Höök. 1998. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol. 6:484-488[CrossRef][Medline]. |
| 9. |
Gillaspy, A. F.,
C. Y. Lee,
S. Sau,
A. L. Cheung, and M. S. Smeltzer.
1998.
Factors affecting the collagen binding capacity of Staphylococcus aureus.
Infect. Immun.
66:3170-3178 |
| 10. |
Gordillo, M. E.,
K. V. Singh, and B. E. Murray.
1993.
Comparison of ribotyping and pulsed-field gel electrophoresis for subspecies differentiation of strains of Enterococcus faecalis.
J. Clin. Microbiol.
31:1570-1574 |
| 11. |
Jacob, A. E., and S. J. Hobbs.
1974.
Conjugal transfer of plasmid-borne multiple antibiotic resistance in Streptococcus faecalis var. zymogenes.
J. Bacteriol.
117:360-372 |
| 12. | Jönsson, K., C. Signäs, H. P. Müller, and M. Lindberg. 1991. Two different genes encode fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence and characterization of the second gene. Eur. J. Biochem. 202:1041-1048[Medline]. |
| 13. |
Lee, C. A., and S. Falkow.
1990.
The ability of Salmonella to enter mammalian cells is affected by bacterial growth state.
Proc. Natl. Acad. Sci. USA
87:4304-4308 |
| 14. |
Malathum, K.,
K. V. Singh,
G. M. Weinstock, and B. E. Murray.
1998.
Repetitive sequence-based PCR versus pulsed-field gel electrophoresis for typing of Enterococcus faecalis at the subspecies level.
J. Clin. Microbiol.
36:211-215 |
| 15. |
Murray, B. E.
1990.
The life and times of the enterococcus.
Clin. Microbiol. Rev.
3:46-65 |
| 16. |
Murray, B. E.,
K. V. Singh,
J. D. Heath,
B. R. Sharma, and G. M. Weinstock.
1990.
Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites.
J. Clin. Microbiol.
28:2059-2063 |
| 17. |
Murray, B. E.,
K. V. Singh,
R. P. Ross,
J. D. Heath,
G. M. Dunny, and G. M. Weinstock.
1993.
Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function.
J. Bacteriol.
175:5216-5223 |
| 18. | Murray, B. E., and G. M. Weinstock. 1999. Enterococci: new aspects of an old organism. Proc. Assoc. Am. Physicians 111:328-334[CrossRef][Medline]. |
| 19. |
Nallapareddy, S. R.,
X. Qin,
G. M. Weinstock,
M. Höök, and B. E. Murray.
2000.
Enterococcus faecalis adhesin, Ace, mediates attachment to extracellular matrix proteins collagen type IV and laminin as well as collagen type I.
Infect. Immun.
68:5218-5224 |
| 20. | Olsén, A., A. Arnqvist, M. Hammar, S. Sukupolvi, and S. Normark. 1993. The RpoS sigma factor relieves H-NS-mediated transcriptional repression of csgA, the subunit gene of fibronectin-binding curli in Escherichia coli. Mol. Microbiol. 7:523-536[CrossRef][Medline]. |
| 21. | Patti, J. M., B. L. Allen, M. J. McGavin, and M. Höök. 1994. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48:585-617[Medline]. |
| 22. |
Patti, J. M.,
H. Jonsson,
B. Guss,
L. M. Switalski,
K. Wiberg,
M. Lindberg, and M. Höök.
1992.
Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin.
J. Biol. Chem.
267:4766-4772 |
| 23. | Qin, X., F. Teng, Y. Xu, K. V. Singh, G. M. Weinstock, and B. E. Murray. 1998. Targeted mutagenesis of enterococcal genes. Methods Cell Sci. 20:21-33. |
| 24. | Rich, R. L., B. Demeler, K. Ashby, C. C. S. Deivanayagam, J. W. Petrich, J. M. Patti, S. V. L. Narayana, and M. Höök. 1998. Domain structure of the Staphylococcus aureus collagen adhesin. Biochemistry 37:15423-15433[CrossRef][Medline]. |
| 25. |
Rich, R. L.,
B. Kreikemeyer,
R. T. Owens,
S. LaBrenz,
S. V. L. Narayana,
G. M. Weinstock,
B. E. Murray, and M. Höök.
1999.
Ace is a collagen-binding MSCRAMM from Enterococcus faecalis.
J. Biol. Chem.
274:26939-26945 |
| 26. | Ryding, U., J. I. Flock, M. Flock, B. Söderquist, and B. Christensson. 1997. Expression of collagen-binding protein and types 5 and 8 capsular polysaccharide in clinical isolates of Staphylococcus aureus. J. Infect. Dis. 176:1096-1099[Medline]. |
| 27. |
Sahm, D. F.,
J. Kissinger,
M. S. Gilmore,
P. R. Murray,
R. Mulder,
J. Solliday, and B. Clarke.
1989.
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis.
Antimicrob. Agents Chemother.
33:1588-1591 |
| 28. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 29. |
Signäs, C.,
G. Raucci,
K. Jönsson,
P. E. Lindgren,
G. M. Anantharamaiah,
M. Höök, and M. Lindberg.
1989.
Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides.
Proc. Natl. Acad. Sci. USA
86:699-703 |
| 30. | Singh, K. V., T. M. Coque, G. M. Weinstock, and B. E. Murray. 1998. In vivo testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for species identification. FEMS Immunol. Med. Microbiol. 21:323-331[Medline]. |
| 31. | Smeltzer, M. S., A. F. Gillaspy, F. L. Pratt, Jr., M. D. Thames, and J. J. Iandolo. 1997. Prevalence and chromosomal map location of Staphylococcus aureus adhesin genes. Gene 196:249-259[CrossRef][Medline]. |
| 32. |
Snodgrass, J. L.,
N. Mohamed,
J. M. Ross,
S. Sau,
C. Y. Lee, and M. S. Smeltzer.
1999.
Functional analysis of the Staphylococcus aureus collagen adhesin B domain.
Infect. Immun.
67:3952-3959 |
| 33. | Sulaiman, A., R. M. Rakita, R. C. Arduino, J. E. Patterson, J. M. Steckelberg, K. V. Singh, and B. E. Murray. 1996. Serological investigation of enterococcal infections using Western blot. Eur. J. Clin. Microbiol. Infect. Dis. 15:826-829[CrossRef][Medline]. |
| 34. | Switalski, L. M., J. M. Patti, W. Butcher, A. G. Gristina, P. Speziale, and M. Höök. 1993. A collagen receptor on Staphylococcus aureus strains isolated from patients with septic arthritis mediates adhesion to cartilage. Mol. Microbiol. 7:99-107[Medline]. |
| 35. | Symersky, J., J. M. Patti, M. Carson, K. House-Pompeo, M. Teale, D. Moore, L. Jin, A. Schneider, L. J. DeLucas, M. Höök, and S. V. L. Narayana. 1997. Structure of the collagen-binding domain from a Staphylococcus aureus adhesin. Nat. Struct. Biol. 4:833-838[CrossRef][Medline]. |
| 36. | Tomayko, J. F., and B. E. Murray. 1995. Analysis of Enterococcus faecalis isolates from intercontinental sources by multilocus enzyme electrophoresis and pulsed-field gel electrophoresis. J. Clin. Microbiol. 33:2903-2907[Abstract]. |
| 37. | VanHeyningen, T., G. Fogg, D. Yates, E. Hanski, and M. Caparon. 1993. Adherence and fibronectin binding are environmentally regulated in the group A streptococci. Mol. Microbiol. 9:1213-1222[Medline]. |
| 38. | Xiao, J., M. Höök, G. M. Weinstock, and B. E. Murray. 1998. Conditional adherence of Enterococcus faecalis to extracellular matrix proteins. FEMS Immunol. Med. Microbiol. 21:287-295[Medline]. |
| 39. | Xu, Y., L. Jiang, B. E. Murray, and G. M. Weinstock. 1997. Enterococcus faecalis antigens in human infections. Infect. Immun. 65:4207-4215[Abstract]. |
| 40. |
Xu, Y.,
B. E. Murray, and G. M. Weinstock.
1998.
A cluster of genes involved in polysaccharide biosynthesis from Enterococcus faecalis OG1RF.
Infect. Immun.
66:4313-4323 |
| 41. |
Xu, Y.,
K. V. Singh,
X. Qin,
B. E. Murray, and G. M. Weinstock.
2000.
Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis.
Infect. Immun.
68:815-823 |
Infection and Immunity, September 2000, p. 5210-5217, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lebreton, F., Riboulet-Bisson, E., Serror, P., Sanguinetti, M., Posteraro, B., Torelli, R., Hartke, A., Auffray, Y., Giard, J.-C.
(2009). ace, Which Encodes an Adhesin in Enterococcus faecalis, Is Regulated by Ers and Is Involved in Virulence. Infect. Immun.
77: 2832-2839
[Abstract] [Full Text] -
Nallapareddy, S. R., Singh, K. V., Okhuysen, P. C., Murray, B. E.
(2008). A Functional Collagen Adhesin Gene, acm, in Clinical Isolates of Enterococcus faecium Correlates with the Recent Success of This Emerging Nosocomial Pathogen. Infect. Immun.
76: 4110-4119
[Abstract] [Full Text] -
Nallapareddy, S. R., Singh, K. V., Murray, B. E.
(2008). Contribution of the Collagen Adhesin Acm to Pathogenesis of Enterococcus faecium in Experimental Endocarditis. Infect. Immun.
76: 4120-4128
[Abstract] [Full Text] -
Liu, Q., Ponnuraj, K., Xu, Y., Ganesh, V. K., Sillanpaa, J., Murray, B. E., Narayana, S. V. L., Hook, M.
(2007). The Enterococcus faecalis MSCRAMM ACE Binds Its Ligand by the Collagen Hug Model. J. Biol. Chem.
282: 19629-19637
[Abstract] [Full Text] -
Tsigrelis, C., Singh, K. V., Coutinho, T. D., Murray, B. E., Baddour, L. M.
(2007). Vancomycin-Resistant Enterococcus faecalis Endocarditis: Linezolid Failure and Strain Characterization of Virulence Factors. J. Clin. Microbiol.
45: 631-635
[Abstract] [Full Text] -
Nallapareddy, S. R., Murray, B. E.
(2006). Ligand-Signaled Upregulation of Enterococcus faecalis ace Transcription, a Mechanism for Modulating Host-E. faecalis Interaction. Infect. Immun.
74: 4982-4989
[Abstract] [Full Text] -
Nallapareddy, S. R., Singh, K. V., Murray, B. E.
(2006). Construction of Improved Temperature-Sensitive and Mobilizable Vectors and Their Use for Constructing Mutations in the Adhesin-Encoding acm Gene of Poorly Transformable Clinical Enterococcus faecium Strains. Appl. Environ. Microbiol.
72: 334-345
[Abstract] [Full Text] -
Rincon, M. T., Cepeljnik, T., Martin, J. C., Lamed, R., Barak, Y., Bayer, E. A., Flint, H. J.
(2005). Unconventional Mode of Attachment of the Ruminococcus flavefaciens Cellulosome to the Cell Surface. J. Bacteriol.
187: 7569-7578
[Abstract] [Full Text] -
Nallapareddy, S. R., Wenxiang, H., Weinstock, G. M., Murray, B. E.
(2005). Molecular Characterization of a Widespread, Pathogenic, and Antibiotic Resistance-Receptive Enterococcus faecalis Lineage and Dissemination of Its Putative Pathogenicity Island. J. Bacteriol.
187: 5709-5718
[Abstract] [Full Text] -
Tomita, H., Ike, Y.
(2004). Tissue-Specific Adherent Enterococcus faecalis Strains That Show Highly Efficient Adhesion to Human Bladder Carcinoma T24 Cells Also Adhere to Extracellular Matrix Proteins. Infect. Immun.
72: 5877-5885
[Abstract] [Full Text] -
Titze-de-Almeida, R., Willems, R. J. L., Top, J., Pereira Rodrigues, I., Fonseca Ferreira, R. II, Boelens, H., Brandileone, M. C. C., Zanella, R. C., Soares Felipe, M. S., van Belkum, A.
(2004). Multilocus Variable-Number Tandem-Repeat Polymorphism among Brazilian Enterococcus faecalis Strains. J. Clin. Microbiol.
42: 4879-4881
[Abstract] [Full Text] -
Kayaoglu, G., Orstavik, D.
(2004). VIRULENCE FACTORS OF ENTEROCOCCUS FAECALIS: RELATIONSHIP TO ENDODONTIC DISEASE. CROBM
15: 308-320
[Abstract] [Full Text] -
Sillanpaa, J., Xu, Y., Nallapareddy, S. R., Murray, B. E., Hook, M.
(2004). A family of putative MSCRAMMs from Enterococcus faecalis. Microbiology
150: 2069-2078
[Abstract] [Full Text] -
Teng, F., Kawalec, M., Weinstock, G. M., Hryniewicz, W., Murray, B. E.
(2003). An Enterococcus faecium Secreted Antigen, SagA, Exhibits Broad-Spectrum Binding to Extracellular Matrix Proteins and Appears Essential for E. faecium Growth. Infect. Immun.
71: 5033-5041
[Abstract] [Full Text] -
Esmay, P. A., Billington, S. J., Link, M. A., Songer, J. G., Jost, B. H.
(2003). The Arcanobacterium pyogenes Collagen-Binding Protein, CbpA, Promotes Adhesion to Host Cells. Infect. Immun.
71: 4368-4374
[Abstract] [Full Text] -
Shepard, B. D., Gilmore, M. S.
(2002). Differential Expression of Virulence-Related Genes in Enterococcus faecalis in Response to Biological Cues in Serum and Urine. Infect. Immun.
70: 4344-4352
[Abstract] [Full Text] -
Nallapareddy, S. R., Duh, R.-W., Singh, K. V., Murray, B. E.
(2002). Molecular Typing of Selected Enterococcus faecalis Isolates: Pilot Study Using Multilocus Sequence Typing and Pulsed-Field Gel Electrophoresis. J. Clin. Microbiol.
40: 868-876
[Abstract] [Full Text] -
McCormick, J. K., Hirt, H., Waters, C. M., Tripp, T. J., Dunny, G. M., Schlievert, P. M.
(2001). Antibodies to a Surface-Exposed, N-terminal Domain of Aggregation Substance Are Not Protective in the Rabbit Model of Enterococcus faecalis Infective Endocarditis. Infect. Immun.
69: 3305-3314
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»